In this article, bone affections in two fre- quently seen pediatric tumoral diseases are discussed.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:In pediatric lymphomas (Non-Hodgkin’s lymphoma and Hodgkin’s disease), changing in bone metabolism can be seen, both because of the disease itself or applied che- motherapeutics.
📊
Key Findings & Data:In pediatric lymphomas (Non-Hodgkin’s lymphoma and Hodgkin’s disease), changing in bone metabolism can be seen, both because of the disease itself or applied che- motherapeutics.
💡
Conclusion & Impact:In this article, bone affections in two fre- quently seen pediatric tumoral diseases are discussed.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Abstract
In pediatric lymphomas (Non-Hodgkin’s lymphoma and Hodgkin’s disease), changing in bone metabolism can be seen, both because of the disease itself or applied che- motherapeutics. In this article, bone affections in two fre- quently seen pediatric tumoral diseases are discussed.
Özet
Çocukluk çağı lenfomalarında (Hodgkin dışı lenfoma ve Hodgkin hastalığında) hastalığın kendisi veya uygulanan kemoterapötikler nedeniyle kemik metabolizmasında de- ğişiklikler görülebilir. Bu makalede çocukluk çağında sık görülen bu iki tümöral hastalığın kemikler üzerine etkileri derlenmiştir.
🔖
Cite This Article
HASPOLAT, K., SÖKER, M. (2010). Childhood lymphoma and bone interaction. Dicle Tıp Dergisi, Cilt: 37 - Sayı: 1, 75–79. https://ajindex.com/articles/349186
Büyükpamukçu M. Hodgkin Dışı Lenfomalar. Klinik Gelişim 2007;2:44-48
Sevinir B, Büyükpamukçu M. Çocukluk çağı lenfomaları. Katkı Pediatri Dergisi 1995;4:476
Rosenthal H, Kolb R, Gratz KF, Reiter A, Galanski M. Bone manifestations in non-Hodgkins lymphoma in childhood and adolescence. Radiologe 2000;40:737-744
Gürmen N. Çocukluk çağında görülen primer ve sekonder malign kemik tümörlerinde radyolojik bulgular. Katkı 1985;6:63-71
Hesseling PB, Hough SF, Nel ED, Van Riet FA, Beneke T, Wessels G. Bone mineral density in long-term survivors of childhood cancer. Int J Cancer Suppl.1998;11:44-47
Lanzkowsky P. Hodgkin Disease. In: Lanzkowsky P ed. Manual of Pediatric Hematology and Oncology. 4th edn. San Diego: Elsevier Academic Pres, 2005;453-90
Arikoski P, Komulainen J. Development of bone mineral density in children with cancer. Pediatric Endocrinology. LWPES/ESPE. 6th. Joint meeting. Montreal. 6-10, 2001;3- 172
Nysom K, Holm K, Michaelsen K, Hertz H, Müller J, Molgaard C. Bone mass after treatment of malignant lymphoma in childhood. Med Pediatr Oncol 2001; 37: 518-524
Brigham BA, Bunn PA, Horton JE et al. Skeletal manifestations in cutaneous T–cell lymphomas. Arch Dermatol 1982;118:461-467
Sala A, Talsma D, Webber C, Posgate S, Atkinson S, Barr R. Bone mıneral status after treatment of malignant lymphoma in childhood and adolescence. Eur J Cancer Care 2007;16:373-379
Köseoğlu V, Büyükpamukçu M, Bayhan H. Lenfoma tanısıyla tedavi edilmiş çocuklarda kemik mineral dansitesi ve serum osteokalsin, carboxyterminal propeptid type I pro- collagen ve ICTP düzeyleri. X. Pediatrik Onkoloji Kongre- si. 22-24 Ekim 1998.Ankara S:91
Redman JR, Bajorunas DR,Wong G et al. Bone mineralization in women following succesful treatment of Hodgkin’s disease. Am J Med 1988; 85:65-72
Bluemke DA, Zerhouni EA. MRI of avascular necrosis of bone. Top Magn Reson Imaging 1996;8:231-246
Frisch B, Bartl R. Osteoporosis. In: Frisch B, Bartl R,eds. Biopsy interpretation of bone and bone marrow. London, 1999:62-69
Morakkabati N, Strunk H, Gutjahr P. MRI diagnosis and follow-up of bilateral necrosis of the humeral head as a complication after chemotherapy. Aktuelle Radiol 1997;7:41-44
Brooks PM. Rheumatic manifestations of neoplasia. Curr Opin Rheumatol 1992;4:90-93
Georgescu L, Quinn GC, Schwartzman S, Paget SA. Lymphoma in patients with rheumatoid arthritis. Semin Arthritis Rheum 1997;26:794-804